We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

BRYAT:BISTBorusan Yatirim ve Pazarlama AS Analysis

Data as of 2026-05-23 - not real-time

TRY 1,940.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

The stock is trading at 1,940 TRY, well below its 20‑day (2,082.2), 50‑day (2,138.8) and 200‑day (2,273.9) simple moving averages, indicating a clear bearish price position. Momentum metrics reinforce this view: the 14‑day RSI sits at 37.4, below the 40 threshold, and the MACD line is negative (-60.7) with a bearish signal crossing the signal line at -39.7. Trading volume has been on a downward trend, and the price is hovering just above the identified support level of 1,800 while facing resistance near 2,277. Despite the technical weakness, the fundamentals paint a contrasting picture: a discounted DCF fair value of 3,460 TRY suggests the market is pricing the shares at roughly 44% discount to intrinsic value. The company boasts a robust dividend yield of 8.56% with a modest payout ratio of 35.5%, supported by ample cash reserves and zero net debt. Operating margins are healthy (> 67%) and free cash flow remains positive, underscoring strong cash generation capacity. However, the sector’s cyclical nature, elevated 30‑day volatility of 39.9%, and Turkey’s macro‑economic environment introduce medium‑to‑high risks that temper the upside potential.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price below all major SMAs indicating bearish short‑term momentum
  • RSI and MACD signaling oversold conditions but no clear reversal
  • Attractive dividend yield providing downside cushion

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • DCF valuation suggests ~44% upside
  • Zero debt and strong free cash flow support earnings stability
  • Sustainable dividend enhances total return

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Long‑term undervaluation relative to intrinsic value
  • Consistent profitability and high payout ratio
  • Potential sector recovery and dividend compounding over time

Key Metrics & Analysis

Financial Health

Revenue Growth107.90%
Profit Margin2386.02%
P/E Ratio11.8
ROE14.16%
ROA7.78%
P/B Ratio1.6
Op. Cash FlowTRY-1354174720
Free Cash FlowTRY2.5B

Technical Analysis

TrendBearish
RSI37.4
SupportTRY 1,800.00
ResistanceTRY 2,277.00
MA 20TRY 2,082.20
MA 50TRY 2,138.80
MA 200TRY 2,273.93
MACDBearish
VolumeDecreasing
Fear & Greed Index91.61

Valuation

Fair ValueTRY 3,460.65
GradeUndervalued
TypeValue
Dividend Yield8.56%

Risk Assessment

Beta0.39
Volatility39.95%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskHigh
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.